Cystatin C is an early marker of contrast-induced nephropathy in patients with sepsis in the intensive care unit
Contrast-induced nephropathy (CIN) is becoming an increasingly common cause of acute kidney injury in hospitalized patients. To evaluate the prevalence of CIN in critically ill patients, we conducted a prospective study on intensive care unit patients who had undergone diagnostic computed tomography...
Main Author: | Fatima I Al-Beladi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | Saudi Journal of Kidney Diseases and Transplantation |
Online Access: | http://www.sjkdt.org/article.asp?issn=1319-2442;year=2015;volume=26;issue=4;spage=718;epage=724;aulast=Al-Beladi |
Similar Items
-
Comparison of Cystatin C and creatinine for early detection of contrast induced nephropathy
by: A. Shinde, et al.
Published: (2015-12-01) -
Cystatin C versus Creatinine as Early Stage Diabetic Nephropathy Marker
by: Atteaya Zaman , Amena Rahim , Muhammad Afzal , Abdul Khaliq Naveed
Published: (2018-06-01) -
Significance of cystatin C for early diagnosis of contrast-induced nephropathy in Iraqi patients undergoing coronary angiography
by: Zahraa Malik Abood, et al.
Published: (2021-01-01) -
Diagnostic accuracy of serum cystatin C for early recognition of contrast induced nephropathy in Western Indians undergoing cardiac catheterization
by: Anand N. Shukla, et al.
Published: (2017-05-01) -
Role of serum cystatin C in the prediction of contrast-induced nephropathy after intra-arterial interventions
by: Zheng-Yu Wang, et al.
Published: (2020-02-01)